Tulane University School of Medicine
Assistant Professor of Medicine, Department of Medicine, Section of Endocrinology
Director, Tulane Center for Osteoporosis and Metabolic Bone Diseases
Ligaturide and ambulatory blood pressure in diabetic patients
Dr. Amna Khan is a physician with clinical training in Medicine-Endocrinology. After completing her residency in Internal Medicine from Long Island College Hospital in Brooklyn, NY, she joined well renowned faculties like Drs. Kitabchi, Dagogo-Jack, Solomon Solomon, Fisher as a Fellow in Endocrinology, Diabetes and Metabolism at University of Tennessee, Memphis. After completing her fellowship, she joined Tulane University in the Section of Endocrinology in December 2009. Her main interests are:
Dr. Khan was the Principal Investigator at Tulane for a multicenter study, Basal Plus: a randomized, multicenter, open labeled, non-inferiority controlled trial investigating the differences of glycemic control among diabetic patients treated with basal plus, basal bolus and sliding scale insulin regimens. Results were presented at the American Diabetes Association annual meeting in Philadelphia, June 2012. Full manuscript published online:
She is also interested in the association of low bone mineral density in patients with Ulcerative Colitis:
Effect of Liraglutide on Ambulatory Blood Pressure in patients with type 2 diabetes
To determine whether Liraglutide lowers systolic BP and pulse pressure through the day compared to placebo in patients with type 2 diabetes who are not on any anti-hypertensive medications or whose BP medications are unchanged over the study period of 8 weeks.
This is a PILOT study to prove this effect which if proven will be extended to a larger, multicenter trial. This will be a double blind, randomized placebo controlled trial over 8 weeks. BP will be monitored with ambulatory BP monitoring devices (ABPM).
1430 Tulane Ave, New Orleans, LA 70112 504-988-5251 email@example.com